Kalaris Therapeutics (KLRS)

NASDAQ:KLRS

US Market

KLRS

Kalaris Therapeutics

RESEARCH TOOLSreports

Want to see KLRS full AI Analyst Report?

Kalaris Therapeutics (KLRS) Ownership - Who Owns Kalaris Therapeutics?

375 Followers

Kalaris Therapeutics (KLRS) Ownership Overview

56.49% Insiders

2.06% Mutual Funds

1.25% Other Institutional Investors

1.24% ETFs

38.96% Public Companies and

Individual Investors

The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 4.55% of the company’s stock is owned by Institutional Investors, 56.49% is owned by Insiders, and 38.96% is owned by Public Companies and Individual Investors.

The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 3.31% of the company’s stock is owned by Institutional Investors, 56.49% is owned by Insiders, and 1.24% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 23, 2026	Brett R Hagen	xxxxxxxxxxxxx	$12869
Feb 17, 2026	Srinivas Akkaraju	xxxxxxxxxxxxx	$5000006

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Jun 30, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$844000

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	12,948,081	Insider	56.47%	65,776,251
	249,346	Institution	1.09%	1,266,678
	249,346	Institution	1.09%	1,266,678
Michael Rockefeller	100,000	Institution	0.44%	508,000
	74,608	Institution	0.33%	379,009
	69,551	Institution	0.30%	353,319
	30,838	Institution	0.13%	156,657
	22,500	Institution	0.10%	114,300
	21,341	Institution	0.09%	108,412
	8,954	Institution	0.04%	45,486

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	249,346	Institution	1.09%	1,266,678
	74,608	Institution	0.33%	379,009
	69,551	Institution	0.30%	353,319
	30,838	Institution	0.13%	156,657
	22,500	Institution	0.10%	114,300
	8,954	Institution	0.04%	45,486
	6,002	Institution	0.03%	30,490
	5,300	Institution	0.02%	26,924
	4,083	Institution	0.02%	20,742

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	176,727	Institution	0.77%	1,019,715
Vanguard Extended Market ETF	72,619	Institution	0.32%	419,012
Simplify Propel Opportunities ETF	21,341	Institution	0.09%	108,412
iShares Micro-Cap ETF	8,699	Institution	0.04%	44,191
Dimensional US Core Equity 1 ETF	3,296	Institution	0.01%	16,744
Dimensional U.S. Core Equity 2 ETF	2,614	Institution	0.01%	13,296
BMO MSCI Innovation Index ETF	384	Institution	<0.01%	1,065
BMO MSCI Genomic Innovation Index ETF Trust Units	255	Institution	<0.01%	707

FAQ

Who Owns Kalaris Therapeutics (KLRS)?

According to the latest TipRanks data, approximately 1.25% of the company's stock is held by institutional investors, 56.49% is held by insiders, and 38.96% is held by retail investors.

What percentage of Kalaris Therapeutics (KLRS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 1.25% of Kalaris Therapeutics (KLRS) stock is held by institutional investors.

What percentage of Kalaris Therapeutics (KLRS) stock is held by retail investors?

According to the latest TipRanks data, approximately 38.96% of Kalaris Therapeutics (KLRS) stock is held by retail investors.

Who owns the most shares of Kalaris Therapeutics (KLRS)?

Srinivas Akkaraju owns the most shares of Kalaris Therapeutics (KLRS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.